tofacitinib
Showing 1 - 25 of 55
Alopecia Areata Trial in Bangkok (Tofacitinib)
Completed
- Alopecia Areata
- Tofacitinib
-
Bangkok, ThailandInstitute of Dermatology
Mar 28, 2022
Rheumatoid Arthritis, Interstitial Lung Disease Trial in Mexico City (Tofacitinib)
Recruiting
- Rheumatoid Arthritis
- Interstitial Lung Disease
- Tofacitinib
-
Mexico City, Tlalpan, MexicoInstituto Nacional de Enfermedades Respiratorias, Ismael Cosío V
Apr 4, 2022
Tofacitinib on Ulcerative Colitis Associated Spondyloarthropathy
Recruiting
- Ulcerative Colitis
- Spondyloarthropathy
- Tofacitinib
-
Palermo, ItalyIBD Unit, Department of Internal Medicine, "Villa Sofia-Cervello
Jun 21, 2022
Systemic Lupus Erythematosus, Cutaneous Lupus Trial in Ann Arbor (Tofacitinib)
Recruiting
- Systemic Lupus Erythematosus
- Cutaneous Lupus
- Tofacitinib
-
Ann Arbor, MichiganUniversity of Michigan Health System: Department of Internal Med
May 2, 2022
Primary Sjögren's Syndrome Trial in Beijing (Tofacitinib)
Recruiting
- Primary Sjögren's Syndrome
- Tofacitinib
-
Beijing, Beijing, ChinaDepartment of Rheumatology and Immunology, Peking University Peo
Feb 28, 2022
TofAcitinib in Routine Care Rheumatoid Arthritis- Cardiovascular
Completed
- Rheumatoid Arthritis
- Tofacitinib
- TNF Inhibitor
-
Boston, MassachusettsBrigham And Women's Hospital
Mar 1, 2022
Sjogren's Syndrome Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (tofacitinib, Placebo)
Recruiting
- Sjogren's Syndrome
- tofacitinib
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Tofacitinib on Body Composition, Bone Mineral Density and Bone
Suspended
- Rheumatoid Arthritis
- Tofacitinib
-
Lille, FranceLille University Hospital
Feb 7, 2022
Takayasu Arteritis Trial in Shanghai (Tofacitinib, Methotrexate)
Recruiting
- Takayasu Arteritis
- Tofacitinib
- Methotrexate
-
Shanghai, Shanghai, ChinaLindi Jiang
Oct 19, 2021
ANCA Associated Vasculitis, Drug Use, JAK-STAT Pathway Deregulation Trial in Shanghai (Tofacitinib)
Completed
- ANCA Associated Vasculitis
- +2 more
- Tofacitinib
-
Shanghai, Shanghai, ChinaDepartment of Rheumatology in Zhongshan hospital, Fudan Universi
Jul 20, 2021
Ulcerative Colitis, Thromboembolism Trial in Madrid (Tofacitinib, Infliximab Adalimumab y Golimumab)
Recruiting
- Ulcerative Colitis
- Thromboembolism
- Tofacitinib
- Infliximab Adalimumab y Golimumab
-
Madrid, SpainHospital Universitario de La Princesa
Aug 2, 2022
ive Alzheimer's Medicines (DREAM) - Tofacitinib vs Abatacept
Completed
- Rheumatoid Arthritis
- Tofacitinib
- Abatacept
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 15, 2021
Tumors With Mesothelin Expression, Epithelioid Mesothelioma, Cholangiocarcinoma, Extrahepatic Trial run by the NCI (LMB-100,
Active, not recruiting
- Neoplasms With Mesothelin Expression
- +3 more
- LMB-100
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2022
Granulomatosis With Polyangiitis Trial in Shanghai (Tofacitinib, Methotrexate)
Recruiting
- Granulomatosis With Polyangiitis
- Tofacitinib
- Methotrexate
-
Shanghai, Shanghai, ChinaDepartment of Rheumatology in Zhongshan hospital, Fudan Universi
Jul 5, 2021
Ulcerative Colitis Trial in Miami (Tofacitinib, Fast Mimicking Diet, Ustekinumab induction)
Recruiting
- Ulcerative Colitis
- Tofacitinib
- +3 more
-
Miami, Florida
- +1 more
Apr 22, 2022
Adherence Of Tofacitinib of Ulcerative Colitis In Clinical
Recruiting
- Ulcerative Colitis
- tofacitinib
-
Alingsås, Sweden
- +12 more
Mar 3, 2022
Rheumatoid Arthritis Trial in Hangzhou (Tofacitinib)
Recruiting
- Rheumatoid Arthritis
- Tofacitinib
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 9, 2021
Arthritis, Rheumatoid Trial in Jinan (Iguratimod, Tofacitinib, Pred)
Recruiting
- Arthritis, Rheumatoid
- Iguratimod
- +2 more
-
Jinan, Shandong, ChinaQilu Hospital
Jun 17, 2021
Rheumatoid Arthritis Trial in Beijing (TLL-018, Tofacitinib)
Recruiting
- Rheumatoid Arthritis
- TLL-018
- Tofacitinib
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jan 12, 2022
Rheumatic Arthritis Trial in Germany (Tofacitinib, Etanercept)
Recruiting
- Rheumatic Arthritis
- Tofacitinib
- Etanercept
-
Berlin, Germany
- +5 more
Mar 1, 2022
Uveitis, Scleritis Trial in Saint Louis (tofacitinib)
Active, not recruiting
- Uveitis
- Scleritis
- tofacitinib
-
Saint Louis, MissouriWashington University in Saint Louis
Jan 7, 2021
COVID-19 Trial in Moscow (Tofacitinib)
Completed
- COVID-19
- Tofacitinib
-
Moscow, Russian FederationSechenov First Moscow State Medical University (Sechenov Univers
Feb 11, 2021
Tofatib Treatment for IgG4-related Disease
Recruiting
- IgG4-related Disease
- tofacitinib
-
Shanghai, Shanghai, ChinaShanghai Changhai Hospital
Nov 15, 2022